This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Agency for Science, Technology and Research, Mirxes Lab Pte. Ltd., National University Hospital (Singapore) Pte. Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: He Cheng: Innovator in Breast Cancer Treatment
Introduction
He Cheng is a notable inventor based in Singapore, recognized for his contributions to medical technology. He has developed a significant patent that addresses critical issues in breast cancer diagnosis and treatment. His work is pivotal in advancing healthcare solutions for patients.
Latest Patents
He Cheng holds a patent for a method of determining and treating breast cancer. This innovative technology involves using miRNA panels to ascertain whether a breast lesion is malignant or benign. This method not only aids in diagnosis but also enhances treatment options for affected individuals.
Career Highlights
Throughout his career, He Cheng has worked with esteemed organizations such as the Agency for Science, Technology and Research and Singapore Health Services Pte Ltd. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking research in the medical field.
Collaborations
He has collaborated with notable colleagues, including Siew Gek Lee-Lim and Ruiyang Zou. Their combined expertise has fostered an environment of innovation and progress in the realm of cancer treatment.
Conclusion
He Cheng's work exemplifies the impact of innovation in healthcare, particularly in the fight against breast cancer. His contributions are invaluable and continue to inspire advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile